Please select an industry below for a detailed listing of companies.
Spinal Kinetics develops innovative and practical motion preservation systems for treating degenerative diseases of the spine. By incorporating an artificial nucleus and annulus into both its cervical and lumbar platforms, Spinal’s M6 artificial disc replicates the anatomic and biomechanics attributes of a natural intervertebral disc.
Tandem Diabetes Care is a developer of the first insulin pump with a touch screen technology for the treatment of diabetes. Unlike standard insulin pumps, this new design offers users a refreshingly simple and streamlined user interface, resulting in significant decrease in learning time and reduction of errors. Ushering in the new age of online management of diabetes, the company’s t:connect Diabetes Management Application enables users and their providers a fast, easy, and visual way to display data from their pump and supported blood glucose meters. This innovation allows them to uncover meaningful insights and trends to better control their diabetes.
Animas designs, manufactures and markets products and services for patients with insulin-requiring diabetes. Its mission is to improve the lifestyle of patients, reduce the long-term morbidity of the disease and lower costs to patients and the health care system. Animas was acquired by Johnson & Johnson in February 2006.
Aspect Medical Systems (NASDAQ: ASPM) is recognized as a pioneer and global market leader in brain monitoring, having led the way to develop proprietary technologies and ultimately improve the quality and cost effectiveness of patient care.
Ciphergen (NASDAQ: CIPH) is a leading provider of enabling tools and collaborative services in the emerging field of protein-based biology research, known as proteomics. Ciphergen develops and manufactures a ProteinChip® System that helps researchers understand the role of proteins in the biology of disease, such as monitoring disease progression and the therapeutic effects of drugs.
Confluent Surgical markets synthetic, polymer-based, sprayable adhesion barriers and surgical sealants. These materials have potential applications across minimally invasive surgery in adhesion prevention, as sealants and hemostats, and in interventional procedures. Confluent was sold to the U.S. Surgical division of Tyco International in August 2006.
EXACT Sciences Corporation (NASDAQ: EXAS) is an applied genomics company whose mission is to play a leading role in the eradication of common cancers by applying advances in the field of genomics to facilitate early detection of disease.
Guava Technologies is a biotechnology company that develops, manufactures and markets unique, high-impact cellular analysis systems for the life science research marketplace. Guava's patented technology has revolutionized the way scientists perform cell-based analysis.
Interlace Medical designs and develops devices for the Interventional Gynecologist to perform office-based procedures to treat diseases and conditions traditionally requiring surgery in the operating room.
Pathway Medical Technologies designs, develops and manufactures innovative medical devices intended for the treatment of arterial disease with a major focus on peripheral artery disease.
Praecis Pharmaceuticals (NASDAQ: PRCS) is a biotechnology company focused on the discovery and development of pharmaceutical products using its proprietary LEAPTM (Ligand Evolution to Active Pharmaceuticals) technology. The company is currently targeting the treatment of prostate cancer, endometriosis and Alzheimer's disease.
Seahorse Bioscience provides industry-leading analytical instruments, biomanufacturing systems and consumable labware products for biological research and drug discovery.
Soteira is developing a system for treatment of vertebral compression fractures in patients with osteoporosis, cancer or traumatic injuries. Soteira’s design provides a superior biomechanical structure and better control of cement flow than competing solutions.
Spinal Concepts provides the surgical community with the most technologically advanced implants used in the treatment of spinal disorders, diseases and injuries. The company is a leader in technology, with more than 40 U.S. patent awards, 22 foreign patents and numerous additional patents pending on product innovations. Spinal Concepts was sold to Abbott Laboratories in 2003.
Transcend Medical is a developer of novel devices for the treatment of glaucoma, the leading cause of adult irreversible blindness. The company has CE mark approval for its CyPass Micro-Stent, which is placed during cataract surgery to control and reduce intraocular pressure all day long. The Transcend Vold Gonio Lens was specifically created for micro-invasive glaucoma surgery and was designed to increase precision and stability with intraoperative gonioscopy and provides surgeons with excellent visualization and control for these procedures.
TYRX delivers site-specific therapy by commercializing proprietary, implantable medical-pharmaceutical combination devices for the surgical markets.
Valeritas developed the first FDA approved fully disposable, non-electronic basal-bolus insulin delivery system. The V-Go delivers insulin at a preset basal rate and on-demand bolus dosing for adults with Type 2 diabetes and is the most simple method to deliver basal-bolus insulin therapy in the market. It contains no electronics, batteries, infusion sets, or programming, fully disposable, and is small and lightweight enough to be worn under clothing.